MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,647 | -12.4% | 73,276 | -9.9% | 0.02% | -32.4% |
| Q1 2023 | $3,022 | -98.9% | 81,306 | +2022.9% | 0.04% | +1133.3% |
| Q3 2022 | $267,000 | -94.2% | 3,830 | -87.8% | 0.00% | -88.9% |
| Q4 2021 | $4,603,000 | -75.9% | 31,382 | -73.4% | 0.03% | -84.6% |
| Q2 2021 | $19,081,000 | +193.8% | 118,131 | +299.5% | 0.18% | +33.6% |
| Q4 2020 | $6,494,000 | +634.6% | 29,567 | +156.9% | 0.13% | +129.8% |
| Q1 2020 | $884,000 | -58.5% | 11,508 | -57.9% | 0.06% | -43.0% |
| Q3 2019 | $2,129,000 | – | 27,338 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |